Alessandra Tucci
Overview
Explore the profile of Alessandra Tucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
2320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tucci A, Re A, Pagani C, Marcheselli L, Marcheselli R, Malaspina F, et al.
Leuk Lymphoma
. 2025 Mar;
:1-9.
PMID: 40055982
The FIL_RECANZ (ClinicalTrials.gov: NCT02371161) is a prospective study evaluating salvage with autologous stem cell transplantation (ASCT) in aggressive B-cell lymphoma patients aged 65 - 75, fit according to the FIL...
2.
Ardigo M, Flenghi L, Ibatici A, Massone C, Quaglino P, Teoli M, et al.
Ital J Dermatol Venerol
. 2025 Mar;
PMID: 40042219
Mogamulizumab is a humanized monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity that targets chemokine receptor type. Several clinical trials and real-life experiences confirmed the efficacy and safety profiles of mogamulizumab...
3.
Guerini A, Mataj E, Borghetti P, Triggiani L, Pegurri L, Nici S, et al.
Adv Radiat Oncol
. 2025 Feb;
10(3):101696.
PMID: 39911722
Purpose: Multiple myeloma (MM) tends to develop resistance to systemic therapy through multiple mechanisms that might as well induce radioresistance, as suggested by preclinical studies. The aim of the present...
4.
Bavieri A, Nizzoli M, Tucci A, Zilioli V, Olivieri J, Bianchi B, et al.
Hemasphere
. 2024 Dec;
8(12):e70049.
PMID: 39698333
No abstract available.
5.
Albano D, Bianchetti N, Talin A, Dondi F, Re A, Tucci A, et al.
Hematol Oncol
. 2024 Nov;
43(1):e70009.
PMID: 39614626
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin lymphoma with poor prognosis. The usefulness of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (2-[F]FDG PET/CT) and its parameters in the evaluation of treatment...
6.
Borlenghi E, Zollner T, Rossi G, Pagani C, Cattaneo C, Malagola M, et al.
Mediterr J Hematol Infect Dis
. 2024 Nov;
16(1):e2024080.
PMID: 39534710
No abstract available.
7.
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, et al.
J Clin Oncol
. 2024 Aug;
42(34):4071-4083.
PMID: 39159403
Purpose: The role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial. Methods: The IELSG37 trial, a randomized noninferiority study, aimed to assess whether irradiation can...
8.
Pulsoni A, Ferrero S, Tosti M, Luminari S, Dondi A, Cavallo F, et al.
Lancet Haematol
. 2024 Jun;
11(7):e499-e509.
PMID: 38937025
Background: The mainstay of treatment for early-stage follicular lymphoma is local radiotherapy, with a possible role for anti-CD20 monoclonal antibody (mAb). We aimed to evaluate the effect of these treatments...
9.
Albano D, Calabro A, Dondi F, Bagnasco S, Tucci A, Bertagna F
Hematol Oncol
. 2024 Mar;
42(2):e3266.
PMID: 38444261
Diffuse Large B-Cell Lymphomas (DLCBL) and mucosa-associated lymphoid tissue (MALT) are the two most common primary gastric lymphomas (PGLs), but have strongly different features. DLBCL is more aggressive, is frequently...
10.
Albano D, Calabro A, Talin A, Dondi F, Pagani C, Tucci A, et al.
Ann Hematol
. 2024 Feb;
103(7):2419-2427.
PMID: 38374254
This retrospective study investigated the prognostic role of disease dissemination features (Dmax and Dmax) measured by 2-[F]FDG PET/CT in newly diagnosed Burkitt Lymphoma (BL) patients, comparing their performance with other...